The outlook of companies tied to iconic drugs like Viagra presents a challenging investment picture. While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the loss of exclusivity in key regions has introduced substantial uncertainty . Investors are now assessing the consequences of lower-co